Home › FDA Advisory Panel To Re-Evaluate Diabetes Drug Avandia In June
 

Keywords :   


FDA Advisory Panel To Re-Evaluate Diabetes Drug Avandia In June

2013-04-14 18:20:38| Biotech - Topix.net

Three years after restricting sales of Avandia , the US Food and Drug Administration has scheduled a health advisory panel to re-evaluate the safety of the diabetes drug, various media outlets reported on Friday.

Tags: june panel drug advisory

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
11.10Viva Flexo Vegas at FTA Fall Technical Conference
11.10Eastern North Pacific Tropical Weather Outlook
11.10Atlantic Tropical Weather Outlook
11.10Talks over 1bn UK port expansion ongoing after row
11.10Maple Leaf Foods unveils Canada Packers as name for new pork company
11.10Evonik Aligning Two Business Lines with New Growth Strategy
11.10Biosecurity in livestock production: Impact on animal and gut health
11.10BASF Awarded a Red Dot for its Unique Automotive Coating Concept
More »